Glycemic control indicators in patients with neonatal diabetes mellitus

被引：12

作者：

Suzuki, Shigeru ^{[1
]}

Koga, Masafumi ^{[2
]}

机构：

[1] Asahikawa Med Univ, Dept Pediat, Asahikawa, Hokkaido 0788510, Japan

[2] Kawanishi City Hosp, Dept Internal Med, Kawanishi, Hyogo 6648533, Japan

来源：

WORLD JOURNAL OF DIABETES | 2014年 / 5卷 / 02期

关键词：

Glycemic control; HbA1c; Glycated albumin; Fructosamine; 1,5-anhydroglucitol; Neonatal diabetes mellitus;

D O I：

10.4239/wjd.v5.i2.198

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Neonatal diabetes mellitus (NDM) is a type of diabetes mellitus caused by genetic abnormality which develops in insulin dependent state within 6 mo after birth. HbA1c is widely used in clinical practice for diabetes mellitus as the gold standard glycemic control indicator; however, fetal hemoglobin (HbF) is the main hemoglobin in neonates and so HbA1c cannot be used as a glycemic control indicator in NDM. Glycated albumin (GA), another glycemic control indicator, is not affected by HbF. We reported that GA can be used as a glycemic control indicator in NDM. However, it was later found that because of increased metabolism of albumin, GA shows an apparently lower level in relation to plasma glucose in NDM; measures to solve this problem were needed. In this review, we outlined the most recent findings concerning glycemic control indicators in neonates or NDM. (C) 2014 Baishideng Publishing Group Co., Limited. All rights reserved.

引用

页码：198 / 208

页数：11

共 87 条

[1] ALTERATIONS IN FRUCTOSAMINE AND GLYCATED ALBUMIN LEVELS DURING CHILDHOOD [J].

ABE, F ;

YANO, M ;

MINAMI, Y ;

UEDA, T ;

CHIKAKIYO, H ;

MIYAMOTO, N ;

SHIRAKAWA, N ;

SHIMA, K .

ANNALS OF CLINICAL BIOCHEMISTRY, 1989, 26 :328-331

[2] Neonatal diabetes mellitus [J].

Aguilar-Bryan, Lydia ;

Bryan, Joseph .

ENDOCRINE REVIEWS, 2008, 29 (03) :265-291

[3] Diagnosis and Classification of Diabetes Mellitus [J].

DIABETES CARE, 2010, 33 :S62-S69

[4]

ARMBRUSTER DA, 1987, CLIN CHEM, V33, P2153

[5] POSTNATAL DECLINE OF HEMOGLOBIN F SYNTHESIS IN NORMAL FULL-TERM INFANTS [J].

BARD, H .

JOURNAL OF CLINICAL INVESTIGATION, 1975, 55 (02) :395-398

[6] Neonatal diabetes and insulin pump therapy [J].

Beardsall, Kathryn ;

Pesterfield, Claire L. ;

Acerini, Carlo L. .

ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 2011, 96 (03) :F223-F224

[7] Albumin synthesis in preterm infants on the first day of life studied with [1-13C] leucine [J].

Bunt, Jan Erik H. ;

Rietveld, Trinet ;

Schierbeek, Henk ;

Wattimena, J. L. Darcos ;

Zimmermann, Luc J. I. ;

van Goudoever, Johannes B. .

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2007, 292 (04) :G1157-G1161

[8] Transition from insulin to glyburide in a 4-month-old girl with neonatal diabetes mellitus caused by a mutation in KCNJ11 [J].

Chan, Yee-Ming ;

Laffel, Lori M. B. .

PEDIATRIC DIABETES, 2007, 8 (04) :235-238

[9] SERUM FRUCTOSAMINE CONCENTRATION IN PATIENTS WITH NEPHROTIC SYNDROME AND WITH CIRRHOSIS OF THE LIVER - THE INFLUENCE OF HYPOALBUMINEMIA AND HYPERGAMMAGLOBULINEMIA [J].

CONSTANTI, C ;

SIMO, JM ;

JOVEN, J ;

CAMPS, J .

ANNALS OF CLINICAL BIOCHEMISTRY, 1992, 29 :437-442

[10] Clinical presentation of 6q24 transient neonatal diabetes mellitus (6q24 TNDM) and genotype-phenotype correlation in an international cohort of patients [J].

Docherty, L. E. ;

Kabwama, S. ;

Lehmann, A. ;

Hawke, E. ;

Harrison, L. ;

Flanagan, S. E. ;

Ellard, S. ;

Hattersley, A. T. ;

Shield, J. P. H. ;

Ennis, S. ;

Mackay, D. J. G. ;

Temple, I. K. .

DIABETOLOGIA, 2013, 56 (04) :758-762

← 1 2 3 4 5 6 7 8 9 →